Listed

Scotts Miracle-Gro Co: Form 10-Q for the period ended Mar 28, 2026

Filed with the SEC on May 6, 2026 and accepted by EDGAR at May 6, 2026, 16:07 ET.

Share

Management's discussion and analysis

As filed, 54,106 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The purpose of this Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is to provide an understanding of our financial condition and results of operations by focusing on changes in certain key measures from year-to-year. This MD&A includes the following sections:

  • Executive summary
  • Results of operations
  • Segment results
  • Liquidity and capital resources
  • Regulatory matters
  • Critical accounting estimates

This MD&A should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in Scotts Miracle-Gro’s Annual Report on Form 10-K for the fiscal year ended September 30, 2025 (the “2025 Annual Report”) and our condensed consolidated financial statements included in this Form 10-Q.

EXECUTIVE SUMMARY

U.S. Consumer consists of our consumer lawn and garden business in the United States. Other primarily consists of our consumer lawn and garden business in Canada. Corporate consists of general and administrative expenses and certain other income and expense items not allocated to the operating segments. See “SEGMENT RESULTS” below for additional information regarding our evaluation of segment performance.

Through our U.S. Consumer and Other segments, we are the leading marketer of branded consumer lawn and garden products in North America. Our products are marketed under some of the most recognized brand names in the industry. Our key consumer lawn and garden brands include Scotts® Turf Builder® lawn fertilizer and Scotts® grass seed products; Miracle-Gro® soil, plant food and gardening products; Ortho® herbicide and pesticide products; and Tomcat® rodent control and animal repellent products. We are the exclusive agent of Monsanto for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products within the United States and certain other specified countries. In addition, we have an equity interest in Bonnie Plants, LLC, a joint venture with AFC, focused on planting, growing, developing, distributing, marketing and selling live plants.

Due to the seasonal nature of the consumer lawn and garden business, significant portions of our U.S. Consumer and Other segment net sales ship to our retail customers during our second and third fiscal quarters, as noted in the following table. Our annual net sales are further concentrated in the second and third fiscal quarters by retailers who rely on our ability to deliver products closer to when consumers buy our products.

Percent of Net Sales from Continuing Operations by Quarter 2025 2024 2023
First Quarter 11.3% 10.2% 12.8%
Second Quarter 42.7% 44.7% 46.7%
Third Quarter 35.6% 34.8% 33.2%
Fourth Quarter 10.4% 10.3% 7.3%

28

Contents THE SCOTTS MIRACLE-GRO COMPANY
(Dollars in millions, except per share data)

Recent Events and Trends Affecting our Business

During the three months ended December 27, 2025, we determined that the Hawthorne business met the criteria to be classified as held for sale, and classified the related assets and liabilities as held for sale on the Condensed Consolidated Balance Sheets for all periods presented. We determined this represents a strategic shift, and therefore, effective in the first quarter of fiscal 2026, we classified our results of operations for all periods presented to reflect the Hawthorne business as a discontinued operation. For the three and six months ended March 28, 2026, we incurred pre-tax charges of $29.6 and $134.4, respectively, related to valuation adjustments to recognize the carrying amount of the Hawthorne business at fair value less estimated costs to sell in the “Loss from discontinued operations, net of tax” line on the Condensed Consolidated Statements of Operations.

On April 8, 2026, we completed the sale of the Hawthorne business in North America to Vireo in exchange for 213.0 million common shares of Vireo, which represented approximately 14% of Vireo’s total outstanding common shares as of the closing date, and a warrant with a five year term to acquire 80.0 million additional common shares of Vireo at a strike price of $0.85 per share. On the closing date, the Hawthorne business held cash and cash equivalents of $35.0 that was transferred to Vireo as part of the sale. Additionally, in connection with the transaction, we entered into a contract manufacturing agreement and agreed to provide Vireo with $20.0 of manufacturing services over a two-year period for no cost. The completion of the divestiture during the third quarter of fiscal 2026 resulted in an ordinary taxable loss that will allow the realization of deferred tax assets to reduce cash taxes paid over the next several fiscal years.

We continue to monitor the impacts of macroeconomic conditions, including elevated interest rates and inflationary pressures on input costs and consumer behavior, as well as geopolitical uncertainty, including the duration and resolution of ongoing conflicts, potential escalation of tensions and global supply chain disruptions, and ongoing changes to global trade policies, including the imposition of tariffs. The impact that these events and conditions will have on our operational and financial performance will depend on future developments, which are difficult to predict. For more information about factors that could impact our business, refer to “ITEM 1A. RISK FACTORS” in the 2025 Annual Report.

RESULTS OF OPERATIONS

Unless specifically stated, all discussion herein refers to results from our continuing operations. The following table sets forth the components of earnings as a percentage of net sales for the three months ended March 28, 2026 and March 29, 2025:

March 28, 2026 % Of Net Sales March 29, 2025 % Of Net Sales
Net sales $1,459.5 100.0% $1,389.7 100.0%
Cost of sales 849.0 58.2 842.3 60.6
Cost of sales—impairment, restructuring and other — — 5.3 0.4
Gross margin 610.5 41.8 542.1 39.0
Operating expenses:
Selling, general and administrative 199.2 13.6 177.8 12.8
Impairment, restructuring and other 2.2 0.2 10.4 0.7
Other expense, net 7.3 0.5 4.2 0.3
Income from operations 401.8 27.5 349.7 25.2
Equity in loss of unconsolidated affiliates 4.5 0.3 5.9 0.4
Interest expense 31.3 2.1 36.6 2.6
Other non-operating expense, net 1.1 0.1 1.2 0.1
Income from continuing operations before income taxes 364.9 25.0 306.0 22.0
Income tax expense from continuing operations 101.6 7.0 85.3 6.1
Net income from continuing operations 263.3 18.0 220.7 15.9
Loss from discontinued operations, net of tax (24.7) (1.7) (3.2) (0.2)
Net income $238.6 16.3% $217.5 15.7%

The sum of the components may not equal due to rounding.

Contents THE SCOTTS MIRACLE-GRO COMPANY
(Dollars in millions, except per share data)

The following table sets forth the components of earnings as a percentage of net sales for the six months ended March 28, 2026 and March 29, 2025:

March 28, 2026 % Of Net Sales March 29, 2025 % Of Net Sales
Net sales $1,814.0 100.0% $1,756.3 100.0%
Cost of sales 1,113.5 61.4 1,119.0 63.7
Cost of sales—impairment, restructuring and other 1.3 0.1 6.7 0.4
Gross margin 699.2 38.5 630.6 35.9
Operating expenses:
Selling, general and administrative 305.1 16.8 291.3 16.6
Impairment, restructuring and other 3.9 0.2 27.0 1.5
Other expense, net 10.2 0.6 8.4 0.5
Income from operations 380.0 20.9 303.9 17.3
Equity in loss of unconsolidated affiliates 17.6 1.0 15.8 0.9
Interest expense 58.5 3.2 70.5 4.0
Other non-operating expense, net 2.3 0.1 2.5 0.1
Income from continuing operations before income taxes 301.6 16.6 215.1 12.2
Income tax expense from continuing operations 86.0 4.7 60.4 3.4
Net income from continuing operations 215.6 11.9 154.7 8.8
Loss from discontinued operations, net of tax (102.0) (5.6) (6.7) (0.4)
Net income $113.6 6.3% $148.0 8.4%

The sum of the components may not equal due to rounding.

Net Sales

Net sales for the three months ended March 28, 2026 were $1,459.5, an increase of 5.0% from net sales of $1,389.7 for the three months ended March 29, 2025. Net sales for the six months ended March 28, 2026 were $1,814.0, an increase of 3.3% from net sales of $1,756.3 for the six months ended March 29, 2025. Factors contributing to the change in net sales are outlined in the following table:

Three Months Ended March 28, 2026 Six Months Ended March 28, 2026
Volume and mix 4.5% 2.5%
Pricing 0.4 0.6
Foreign exchange rates 0.1 0.2
Change in net sales 5.0% 3.3%

The increase in net sales for the three months ended March 28, 2026 as compared to the three months ended March 29, 2025 was primarily driven by:

  • higher sales volume in our U.S. Consumer segment driven by soils, grass seed, fertilizer, plant food and controls products, partially offset by lower sales of mulch products;
  • higher net sales associated with the Roundup® marketing agreement; and
  • increased pricing in our U.S. Consumer segment.
Contents THE SCOTTS MIRACLE-GRO COMPANY
(Dollars in millions, except per share data)

The increase in net sales for the six months ended March 28, 2026 as compared to the six months ended March 29, 2025 was primarily driven by:

  • higher sales volume in our U.S. Consumer segment driven by soils, grass seed and fertilizer products, partially offset by lower sales of mulch products;
  • higher net sales associated with the Roundup® marketing agreement; and
  • increased pricing in our U.S. Consumer segment.

Cost of Sales

The following table shows the major components of cost of sales:

Three Months Ended March 28, 2026 March 29, 2025 Six Months Ended March 28, 2026 March 29, 2025
Materials $455.9 $436.0 $572.3 $559.5
Manufacturing labor and overhead 201.9 216.6 258.0 276.5
Distribution and warehousing 158.7 162.6 231.3 233.9
Costs associated with Roundup® marketing agreement 32.5 27.1 51.9 49.1
Cost of sales 849.0 842.3 1,113.5 1,119.0
Cost of sales—impairment, restructuring and other — 5.3 1.3 6.7
$849.0 $847.6 $1,114.8 $1,125.7

Factors contributing to the change in cost of sales are outlined in the following table:

Three Months Ended March 28, 2026 Six Months Ended March 28, 2026
Costs associated with Roundup® marketing agreement $5.4 $2.8
Material cost changes 4.1 2.6
Foreign exchange rates 2.0 2.3
Volume, mix and other (4.8) (13.2)
6.7 (5.5)
Impairment, restructuring and other (5.3) (5.4)
Change in cost of sales $1.4 $(10.9)

The increase in cost of sales for the three months ended March 28, 2026 as compared to the three months ended March 29, 2025 was primarily driven by:

  • higher sales volume in our U.S. Consumer segment;
  • an increase in costs associated with the Roundup® marketing agreement; and
  • higher material costs in our U.S. Consumer segment;
  • partially offset by lower manufacturing costs included within “volume, mix and other” in our U.S. Consumer segment; and
  • a decrease in impairment, restructuring and other charges.

The decrease in cost of sales for the six months ended March 28, 2026 as compared to the six months ended March 29, 2025 was primarily driven by:

  • lower manufacturing costs included within “volume, mix and other” in our U.S. Consumer segment; and
  • a decrease in impairment, restructuring and other charges;
  • partially offset by higher sales volume in our U.S. Consumer segment;
  • an increase in costs associated with the Roundup® marketing agreement; and
  • higher material costs in our U.S. Consumer segment.
Contents THE SCOTTS MIRACLE-GRO COMPANY
(Dollars in millions, except per share data)

Gross Margin

As a percentage of net sales, our gross margin rate was 41.8% and 39.0% for the three months ended March 28, 2026 and March 29, 2025, respectively, and was 38.5% and 35.9% for the six months ended March 28, 2026 and March 29, 2025, respectively. Factors contributing to the change in gross margin rate are outlined in the following table:

Three Months Ended March 28, 2026 Six Months Ended March 28, 2026
Volume, mix and other 2.0% 1.5%
Roundup® commissions and reimbursements 0.5 0.5
Pricing 0.2 0.4
Material costs (0.3) (0.1)
2.4% 2.3%
Impairment, restructuring and other 0.4 0.3
Change in gross margin rate 2.8% 2.6%

The increase in gross margin rate for the three and six months ended March 28, 2026 as compared to the three and six months ended March 29, 2025 was primarily driven by:

  • favorable mix associated with our U.S. Consumer segment;
  • higher commission associated with the Roundup® marketing agreement;
  • lower manufacturing costs included within “volume, mix and other” in our U.S. Consumer segment;
  • increased pricing in our U.S. Consumer segment; and
  • a decrease in impairment, restructuring and other charges;
  • partially offset by higher material costs in our U.S. Consumer segment.

Selling, General and Administrative Expenses

The following table sets forth the components of selling, general and administrative expenses (“SG&A”):

Three Months Ended March 28, 2026 March 29, 2025 Six Months Ended March 28, 2026 March 29, 2025
Advertising $81.2 $61.8 $102.3 $79.3
Share-based compensation 18.1 12.9 24.8 24.6
Research and development 7.3 7.9 17.1 14.5
Amortization of intangibles 0.7 0.7 1.3 1.4
Other selling, general and administrative 91.9 94.5 159.6 171.5
$199.2 $177.8 $305.1 $291.3

SG&A increased $21.4, or 12.0%, during the three months ended March 28, 2026 compared to the three months ended March 29, 2025. Advertising expense increased $19.4, or 31.4%, due to higher media spending in our U.S. Consumer segment. Share-based compensation expense, which excludes certain advertising expenses paid for in Common Shares for the three months ended March 29, 2025, increased $5.2, or 40.3%, primarily due to the timing of long-term incentive compensation grants. Other SG&A decreased $2.6, or 2.8%, driven by lower short-term variable cash incentive compensation expense.

SG&A increased $13.8, or 4.7%, during the six months ended March 28, 2026 compared to the six months ended March 29, 2025. Advertising expense increased $23.0, or 29.0%, due to higher media spending in our U.S. Consumer segment. Other SG&A decreased $11.9, or 6.9%, driven by lower short-term variable cash incentive compensation expense partially offset by higher marketing spend.

Contents THE SCOTTS MIRACLE-GRO COMPANY
(Dollars in millions, except per share data)

Impairment, Restructuring and Other

Activity described herein is classified within the “Cost of sales—impairment, restructuring and other” and “Impairment, restructuring and other” lines in the Condensed Consolidated Statements of Operations. The following table details impairment, restructuring and other charges for each of the periods presented:

Cost of sales—impairment, restructuring and other: Three Months Ended March 28, 2026 March 29, 2025 Six Months Ended March 28, 2026 March 29, 2025
Restructuring and other charges, net $— $3.4 $1.3 $4.2
Right-of-use asset impairments — 1.9 — 2.5
Operating expenses—impairment, restructuring and other:
Restructuring and other charges, net 2.2 10.4 3.9 20.0
Loss on exchange of convertible debt investment — — — 7.0
Total impairment, restructuring and other charges, net $2.2 $15.7 $5.2 $33.7

Impairment, restructuring and other charges for the three and six months ended March 28, 2026 were not material.

During the three and six months ended March 29, 2025, we incurred employee and executive severance charges of $3.0 in our U.S. Consumer segment in the “Cost of sales—impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations. During the three and six months ended March 29, 2025, we incurred employee and executive severance charges of $3.3 in our U.S. Consumer segment and $2.1 and $11.6, respectively, at Corporate in the “Impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations.

During the three and six months ended March 29, 2025, we incurred a non-cash loss of $0.0 and $7.0, respectively, in the “Impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations related to the exchange of our convertible debt investment in RIV Capital for an investment in FLUENT.

During fiscal 2022, we began implementing a series of Company-wide organizational changes and initiatives intended to create operational and management-level efficiencies. As part of this restructuring initiative, we reduced the size of our supply chain network, reduced staffing levels and implemented other cost-reduction initiatives. During the three and six months ended March 29, 2025, we incurred costs of $2.3 and $3.7, respectively, in our U.S. Consumer segment in the “Cost of sales—impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations associated with this restructuring initiative.

Other Expense, net

Other expense is comprised of activities such as the discount on sales of accounts receivable under the Master Receivables Purchase Agreement, royalty income from the licensing of certain of our brand names and foreign exchange transaction gains and losses. Other expense was $7.3 and $4.2 for the three months ended March 28, 2026 and March 29, 2025, respectively; and was $10.2 and $8.4 for the six months ended March 28, 2026 and March 29, 2025, respectively.

Income from Operations

Income from operations was $401.8 for the three months ended March 28, 2026, an increase of 14.9% compared to $349.7 for the three months ended March 29, 2025; and was $380.0 for the six months ended March 28, 2026, an increase of 25.0% compared to $303.9 for the six months ended March 29, 2025. For the three and six months ended March 28, 2026, the increase was primarily driven by higher net sales, a higher gross margin rate and lower impairment, restructuring and other charges, partially offset by higher SG&A.

Contents THE SCOTTS MIRACLE-GRO COMPANY
(Dollars in millions, except per share data)

Equity in Loss of Unconsolidated Affiliates

Equity in loss of unconsolidated affiliates was $4.5 and $5.9 for the three months ended March 28, 2026 and March 29, 2025, respectively; and was $17.6 and $15.8 for the six months ended March 28, 2026 and March 29, 2025, respectively. Equity in loss of unconsolidated affiliates associated with Bonnie Plants, LLC was $4.5 and $15.1 for the three and six months ended March 28, 2026, respectively, compared to $5.9 and $15.8 for the three and six months ended March 29, 2025, respectively. We anticipated a net loss for Bonnie Plants, LLC in the second quarter due to the seasonal nature of its business, in which sales are heavily weighted to the spring and summer selling periods during our third fiscal quarter. During the three months ended December 27, 2025, our investment balance in FLUENT was reduced to zero, and we discontinued equity method recognition of our proportionate share of FLUENT losses.

Interest Expense

Interest expense was $31.3 for the three months ended March 28, 2026, a decrease of 14.5% compared to $36.6 for the three months ended March 29, 2025; and was $58.5 for the six months ended March 28, 2026, a decrease of 17.0% compared to $70.5 for the six months ended March 29, 2025. For the three months ended March 28, 2026, the decrease was driven by lower average borrowings of $162.1 and a decrease in our weighted average interest rate, net of the impact of interest rate swaps, of 50 basis points. For the six months ended March 28, 2026, the decrease was driven by lower average borrowings of $166.9 and a decrease in our weighted average interest rate, net of the impact of interest rate swaps, of 60 basis points. The decrease in average borrowings was driven by our focus on using available cash flow to reduce our debt. The decrease in our weighted average interest rate was primarily driven by lower borrowing rates under the Seventh A&R Credit Agreement.

Income Tax Expense from Continuing Operations

The effective tax rates related to continuing operations for the six months ended March 28, 2026 and March 29, 2025 were 28.5% and 28.1%, respectively. The effective tax rate used for interim purposes is based on our best estimate of factors impacting the effective tax rate for the full fiscal year. Factors affecting the estimated effective tax rate include assumptions as to income by jurisdiction (domestic and foreign), the availability and utilization of tax credits and the existence of elements of income and expense that may not be taxable or deductible. The estimated effective tax rate is subject to revision in later interim periods and at fiscal year-end as facts and circumstances change during the course of the fiscal year. There can be no assurance that the effective tax rate estimated for interim financial reporting purposes will approximate the effective tax rate determined at fiscal year-end.

Net Income from Continuing Operations

Net income from continuing operations was $263.3, or $4.46 per diluted share, for the three months ended March 28, 2026 compared to $220.7, or $3.78 per diluted share, for the three months ended March 29, 2025. The increase was driven by higher net sales, a higher gross margin rate, lower impairment, restructuring and other charges and lower interest expense, partially offset by higher SG&A and higher income tax expense.

Diluted average common shares used in the diluted net income per common share from continuing operations calculation for the three months ended March 28, 2026 and March 29, 2025 were 59.1 million and 58.4 million, respectively, which included potential common shares of 1.0 million and 0.8 million, respectively. The increase in diluted average common shares was primarily the result of the exercise and issuance of share-based compensation awards.

Net income from continuing operations was $215.6, or $3.65 per diluted share, for the six months ended March 28, 2026 compared to $154.7, or $2.64 per diluted share, for the six months ended March 29, 2025. The increase was driven by higher net sales, a higher gross margin rate, lower impairment, restructuring and other charges and lower interest expense, partially offset by higher SG&A and higher income tax expense.

Diluted average common shares used in the diluted net income per common share from continuing operations calculation for the six months ended March 28, 2026 and March 29, 2025 were 59.0 million and 58.6 million, respectively, which included potential common shares of 1.0 million and 1.1 million, respectively. The increase in diluted average common shares was primarily the result of the exercise and issuance of share-based compensation awards.

Loss from Discontinued Operations, net of tax

Loss from discontinued operations, net of tax, associated with our Hawthorne business was $24.7 and $3.2 for the three months ended March 28, 2026 and March 29, 2025, respectively; and was $102.0 and $6.7 for the six months ended March 28, 2026 and March 29, 2025, respectively. During the three and six months ended March 28, 2026, we incurred pre-tax charges of $29.6 and $134.4, respectively, related to valuation adjustments to recognize the carrying amount of the Hawthorne business at fair value less estimated costs to sell.

Contents THE SCOTTS MIRACLE-GRO COMPANY
(Dollars in millions, except per share data)

SEGMENT RESULTS

As a result of the classification of the Hawthorne business as a discontinued operation, our reportable segments for the three and six months ended March 28, 2026 differ from prior periods. The prior period amounts have been reclassified to reflect the removal of Hawthorne as a reportable segment. Segment performance is evaluated based on several factors, including income (loss) from continuing operations before income taxes, amortization, impairment, restructuring and other charges (“Segment Profit (Loss)”), which is a non-GAAP financial measure. We believe this measure is indicative of performance trends and the overall earnings potential of each segment.

The following table sets forth net sales by segment:

Three Months Ended March 28, 2026 March 29, 2025 Six Months Ended March 28, 2026 March 29, 2025
U.S. Consumer reportable segment $1,377.0 $1,311.5 $1,705.5 $1,652.4
Other non-reportable operating segment 82.5 78.2 108.5 103.9
Consolidated $1,459.5 $1,389.7 $1,814.0 $1,756.3

The following table sets forth Segment Profit (Loss) as well as a reconciliation to income from continuing operations before income taxes, the most directly comparable measure prepared in accordance with GAAP:

Three Months Ended March 28, 2026 March 29, 2025 Six Months Ended March 28, 2026 March 29, 2025
U.S. Consumer Segment Profit (Non-GAAP) $437.3 $392.1 $446.3 $402.0
Other non-reportable operating segment profit 12.1 9.0 10.2 6.0
Corporate (44.7) (35.0) (70.0) (69.0)
Intangible asset amortization (0.7) (0.7) (1.3) (1.4)
Impairment, restructuring and other (2.2) (15.7) (5.2) (33.7)
Equity in loss of unconsolidated affiliates (4.5) (5.9) (17.6) (15.8)
Interest expense (31.3) (36.6) (58.5) (70.5)
Other non-operating expense, net (1.1) (1.2) (2.3) (2.5)
Income from continuing operations before income taxes (GAAP) $364.9 $306.0 $301.6 $215.1

U.S. Consumer

U.S. Consumer segment net sales were $1,377.0 in the second quarter of fiscal 2026, an increase of 5.0% from second quarter of fiscal 2025 net sales of $1,311.5; and were $1,705.5 for the first six months of fiscal 2026, an increase of 3.2% from the first six months of fiscal 2025 net sales of $1,652.4. For the second quarter of fiscal 2026, the increase was driven by higher sales volume of 4.7% and increased pricing of 0.3%. For the six months ended March 28, 2026, the increase was driven by higher sales volume of 2.6% and increased pricing of 0.6%. Higher sales volume for the three months ended March 28, 2026 was driven by soils, grass seed, fertilizer, plant food and controls products, partially offset by lower sales of mulch products. Higher sales volume for the six months ended March 28, 2026 was driven by soils, grass seed and fertilizer products, partially offset by lower sales of mulch products.

U.S. Consumer Segment Profit was $437.3 in the second quarter of fiscal 2026, an increase of 11.5% from second quarter of fiscal 2025 Segment Profit of $392.1; and was $446.3 for the first six months of fiscal 2026, an increase of 11.0% from the first six months of fiscal 2025 Segment Profit of $402.0. For the three and six months ended March 28, 2026, the increase was primarily due to higher net sales and a higher gross margin rate, partially offset by higher SG&A.

Other

Other segment net sales were $82.5 in the second quarter of fiscal 2026, an increase of 5.5% from second quarter of fiscal 2025 net sales of $78.2; and were $108.5 for the first six months of fiscal 2026, an increase of 4.4% from the first six months of fiscal 2025 net sales of $103.9. For the second quarter of fiscal 2026, the increase was driven by favorable foreign exchange rates of 3.4%, increased pricing of 1.1% and higher sales volume of 1.0%. For the six months ended March 28, 2026, the increase was driven by favorable foreign exchange rates of 2.8%, increased pricing of 1.2% and higher sales volume of 0.4%.

Contents THE SCOTTS MIRACLE-GRO COMPANY
(Dollars in millions, except per share data)

Other Segment Profit was $12.1 in the second quarter of fiscal 2026, an increase of 34.4% from second quarter of fiscal 2025 Segment Profit of $9.0; and was $10.2 for the first six months of fiscal 2026, an increase of 70.0% from the first six months of fiscal 2025 Segment Profit of $6.0. For the three and six months ended March 28, 2026, the increase was driven by higher net sales and a higher gross margin rate.

Corporate

Corporate expenses were $44.7 in the second quarter of fiscal 2026 compared to $35.0 for the second quarter of fiscal 2025; and were $70.0 for the first six months of fiscal 2026, an increase of 1.4% from the first six months of fiscal 2025 expenses of $69.0. For the second quarter of fiscal 2026, the increase was primarily driven by the timing of long-term incentive compensation grants, partially offset by lower short-term variable incentive compensation expense.

LIQUIDITY AND CAPITAL RESOURCES

The following table summarizes cash activities:

Six Months Ended March 28, 2026 March 29, 2025
Net cash used in operating activities $(150.4) $(257.2)
Net cash used in investing activities (45.4) (34.7)
Net cash provided by financing activities 168.2 237.9

Operating Activities

Cash used in operating activities totaled $150.4 for the six months ended March 28, 2026 compared to $257.2 for the six months ended March 29, 2025. The decrease was driven by higher sales and the timing of inventory production, partially offset by higher short-term variable cash incentive compensation payments and higher SG&A.

Investing Activities

Cash used in investing activities totaled $45.4 for the six months ended March 28, 2026 compared to $34.7 for the six months ended March 29, 2025. Cash used for investments in property, plant and equipment during the first six months of fiscal 2026 and 2025 was $38.6 and $37.6, respectively. During the six months ended March 28, 2026 and March 29, 2025, we had net other investing cash (outflows) inflows of $(6.8) and $2.9, respectively.

Financing Activities

Cash provided by financing activities totaled $168.2 for the six months ended March 28, 2026 compared to $237.9 for the six months ended March 29, 2025. During the six months ended March 28, 2026, we had net borrowings on our debt instruments of $241.0 due to our seasonal working capital build. We also paid dividends of $77.8, financing and issuance fees of $8.7 and received cash from the exercise of stock options of $3.3 (which also includes amounts received from employee purchases under the employee stock purchase plan). During the six months ended March 29, 2025, we had net borrowings on our debt instruments of $321.2, paid dividends of $78.0 and received cash from the exercise of stock options of $10.0 (which also includes amounts received from employee purchases under the employee stock purchase plan). During the six months ended March 28, 2026 and March 29, 2025, we repurchased Common Shares for $11.6 and $18.3, respectively (which includes cash paid to tax authorities to satisfy statutory income tax withholding obligations related to share-based compensation). In addition, during the six months ended March 28, 2026 and March 29, 2025, we had other financing cash inflows of $22.0 and $3.0, respectively, primarily related to collections of previously sold accounts receivable not yet submitted to the buyer.

Share Repurchases

On December 19, 2025, our Board of Directors authorized a share repurchase program, with no expiration date, for the repurchase of up to $500.0 of Common Shares. There have been no share repurchases under this authorization as of March 28, 2026.

Contents THE SCOTTS MIRACLE-GRO COMPANY
(Dollars in millions, except per share data)

Accounts Receivable Sales

We are party to a Master Receivables Purchase Agreement, which is uncommitted and expires on September 1, 2026, under which we may sell up to $750.0 of available and eligible outstanding customer accounts receivable generated by sales to five specified customers. Transactions under the Master Receivables Purchase Agreement are accounted for as sales of accounts receivable, and the receivables sold are removed from the Condensed Consolidated Balance Sheets at the time of the sales transaction. Proceeds received from the sales of accounts receivable are classified as operating cash flows and collections of previously sold accounts receivable not yet submitted to the buyer are classified as financing cash flows in the Condensed Consolidated Statements of Cash Flows. We record the discount on sales in the “Other expense, net” line in the Condensed Consolidated Statements of Operations. At March 28, 2026, March 29, 2025 and September 30, 2025, net receivables derecognized were $654.1, $598.2 and $163.3, respectively. During the three months ended March 28, 2026 and March 29, 2025, proceeds from the sale of receivables under the Master Receivables Purchase Agreement totaled $813.8 and $748.2, respectively, and the total discount recorded on sales was $8.5 and $7.9, respectively. During the six months ended March 28, 2026 and March 29, 2025, proceeds from the sale of receivables under the Master Receivables Purchase Agreement totaled $1,068.5 and $1,022.2, respectively, and the total discount recorded on sales was $11.4 and $11.2, respectively.

Supplier Finance Program

We have an agreement to provide a supplier finance program which facilitates participating suppliers’ ability to finance our payment obligations with a designated third-party financial institution. Participating suppliers may, at their sole discretion, elect to finance our payment obligations prior to their scheduled due dates at a discounted price to the participating financial institution. Our obligations to our suppliers, including amounts due and scheduled payment dates, are not impacted by suppliers’ decisions to finance amounts under this arrangement. The payment terms that we negotiate with our suppliers are consistent, regardless of whether a supplier participates in the program. Our current payment terms with a majority of our suppliers generally range from 30 to 60 days, which we deem to be commercially reasonable. Our outstanding payment obligations under our supplier finance program were $42.9, $32.1 and $13.9 at March 28, 2026, March 29, 2025 and September 30, 2025, respectively, and are recorded within accounts payable in the Condensed Consolidated Balance Sheets. The associated payments were $154.7 and $153.1 for the six months ended March 28, 2026 and March 29, 2025, respectively, and are classified as operating activities in the Condensed Consolidated Statements of Cash Flows.

Cash and Cash Equivalents

Our cash and cash equivalents were held in cash depository accounts with major financial institutions around the world or invested in high-quality, short-term liquid investments having original maturities of three months or less. The cash and cash equivalents balances, including cash and cash equivalents classified within current assets held for sale, of $9.1, $16.9 and $36.6 as of March 28, 2026, March 29, 2025 and September 30, 2025, respectively, included $4.8, $9.4 and $4.2, respectively, held by controlled foreign corporations. As of March 28, 2026, we maintain our assertion of indefinite reinvestment of the earnings of all material foreign subsidiaries.

Borrowing Agreements

Credit Facilities

Our primary sources of liquidity are cash generated by operations and borrowings under our credit facilities, which are guaranteed by substantially all of Scotts Miracle-Gro’s domestic subsidiaries. On November 21, 2025, we entered into the Seventh A&R Credit Agreement, providing the Company and certain of its subsidiaries with five-year senior secured loan facilities in the aggregate principal amount of $2,000.0, comprised of a revolving credit facility of $1,500.0 and a term loan in the original principal amount of $500.0. The Seventh A&R Credit Agreement also provides us with the right to seek additional committed credit under the agreement in an aggregate amount of up to $500.0 plus an unlimited additional amount, subject to certain specified financial and other conditions. The Seventh A&R Credit Agreement will be available for issuance of letters of credit up to $100.0 and will terminate on November 21, 2030. The terms of the Seventh A&R Credit Agreement include customary representations and warranties, affirmative and negative covenants, financial covenants and events of default.

Borrowings under the Seventh A&R Credit Agreement bear interest at variable rates derived from the prevailing U.S. Prime Rate, Federal Reserve Bank of New York Rate, Secured Overnight Financing Rate, Euro Interbank Offered Rate, Canadian Prime Rate or Canadian Overnight Repo Rate Average (all as defined in the Seventh A&R Credit Agreement), based on our election, plus a spread that depends on our quarterly-tested leverage ratio.

Contents THE SCOTTS MIRACLE-GRO COMPANY
(Dollars in millions, except per share data)

At March 28, 2026, we had letters of credit outstanding in the aggregate principal amount of $93.2, and had $1,155.6 of borrowing availability under the Seventh A&R Credit Agreement. The weighted average interest rates on average borrowings under the credit facilities, excluding the impact of interest rate swaps, were 6.4% and 7.8% for the six months ended March 28, 2026 and March 29, 2025, respectively.

The Seventh A&R Credit Agreement contains, among other obligations, an affirmative covenant regarding our leverage ratio determined as of the end of each of our fiscal quarters, calculated as average total indebtedness divided by our Adjusted EBITDA. The maximum permitted leverage ratio is 5.00. Our leverage ratio was 3.71 at March 28, 2026. The Seventh A&R Credit Agreement also contains an affirmative covenant regarding our interest coverage ratio determined as of the end of each of our fiscal quarters, calculated as Adjusted EBITDA divided by interest expense, as described in the Seventh A&R Credit Agreement. The minimum required interest coverage ratio is (i) 3.00 for each of the fiscal quarters within fiscal 2026, (ii) 3.25 for each of the fiscal quarters within fiscal 2027 and (iii) 3.50 for fiscal quarters thereafter. Our interest coverage ratio was 5.62 at March 28, 2026.

The Seventh A&R Credit Agreement allows us to make unlimited restricted payments (as defined in the Seventh A&R Credit Agreement), including dividend payments on, and repurchases of, Common Shares, as long as the leverage ratio resulting from the making of such restricted payments is 4.00 or less. Otherwise, we are limited to restricted payments in an aggregate amount for each fiscal year not to exceed $225.0.

Senior Notes

On December 15, 2016, Scotts Miracle-Gro issued $250.0 aggregate principal amount of 5.250% Senior Notes with a maturity date of December 15, 2026. The 5.250% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with our existing and future unsecured senior debt. The 5.250% Senior Notes have interest payment dates of June 15 and December 15 of each year. At March 28, 2026, the $250.0 aggregate principal amount of the 5.250% Senior Notes is classified in the “Current portion of debt” line in the Condensed Consolidated Balance Sheets as it is payable within one year. We intend to repay the 5.250% Senior Notes during fiscal 2026 using a combination of cash flow from operations and available borrowing capacity under the Seventh A&R Credit Agreement.

On October 22, 2019, Scotts Miracle-Gro issued $450.0 aggregate principal amount of 4.500% Senior Notes due 2029. The 4.500% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with our existing and future unsecured senior debt. The 4.500% Senior Notes have interest payment dates of April 15 and October 15 of each year.

On March 17, 2021, Scotts Miracle-Gro issued $500.0 aggregate principal amount of 4.000% Senior Notes due 2031. The 4.000% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with our existing and future unsecured senior debt. The 4.000% Senior Notes have interest payment dates of April 1 and October 1 of each year.

On August 13, 2021, Scotts Miracle-Gro issued $400.0 aggregate principal amount of 4.375% Senior Notes due 2032. The 4.375% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with our existing and future unsecured senior debt. The 4.375% Senior Notes have interest payment dates of February 1 and August 1 of each year.

Substantially all of Scotts Miracle-Gro’s directly and indirectly owned domestic subsidiaries serve as guarantors of the 5.250% Senior Notes, the 4.500% Senior Notes, the 4.000% Senior Notes and the 4.375% Senior Notes.

Contents THE SCOTTS MIRACLE-GRO COMPANY
(Dollars in millions, except per share data)

Interest Rate Swap Agreements

We enter into interest rate swap agreements with major financial institutions that effectively convert a portion of our variable-rate debt to a fixed rate. Interest payments made between the effective date and expiration date are hedged by the swap agreements. Swap agreements that were hedging interest payments as of March 28, 2026, March 29, 2025 and September 30, 2025 had a maximum total U.S. dollar equivalent notional amount of $450.0. The notional amount, effective date, expiration date and rate of each of the swap agreements outstanding at March 28, 2026 are shown in the table below:

Notional Amount ($) Effective Date (a) Expiration Date Fixed Rate
150 6/7/2023 4/7/2027 3.37%
50 6/7/2023 4/7/2027 3.34%
100 (b) 11/20/2023 3/22/2027 4.74%
150 (b) 9/20/2024 9/20/2029 4.25%
100 4/8/2027 4/8/2030 3.40%

(a) The effective date refers to the date on which interest payments are first hedged by the applicable swap agreement.

(b) Notional amount adjusts in accordance with a specified seasonal schedule. This represents the maximum notional amount at any point in time.

Availability and Use of Cash

We believe that our cash flows from operations and borrowings under our agreements described herein will be sufficient to meet debt service, capital expenditures and working capital needs for the foreseeable future. However, we cannot ensure that our business will generate sufficient cash flow from operations or that future borrowings will be available under our borrowing agreements in amounts sufficient to pay indebtedness or fund other liquidity needs. Actual results of operations will depend on numerous factors, many of which are beyond our control as further discussed in the 2025 Annual Report, under “ITEM 1A. RISK FACTORS — Risks Related to Our M&A, Lending and Financing Activities — Our indebtedness could limit our flexibility and adversely affect our financial condition.”

Financial Disclosures About Guarantors and Issuers of Guaranteed Securities

The 5.250% Senior Notes, 4.500% Senior Notes, 4.000% Senior Notes and 4.375% Senior Notes were issued by Scotts Miracle-Gro on December 15, 2016, October 22, 2019, March 17, 2021 and August 13, 2021, respectively. The Senior Notes are guaranteed by certain consolidated domestic subsidiaries of Scotts Miracle-Gro (collectively, the “Guarantors”) and, therefore, we report summarized financial information in accordance with SEC Regulation S-X, Rule 13-01, “Guarantors and Issuers of Guaranteed Securities Registered or Being Registered.”

The guarantees are “full and unconditional,” as those terms are used in Regulation S-X, Rule 3-10(b)(3), except that a Guarantor’s guarantee will be released in certain circumstances set forth in the indentures governing the Senior Notes, such as: (i) upon any sale or other disposition of all or substantially all of the assets of the Guarantor (including by way of merger or consolidation) to any person other than Scotts Miracle-Gro or any “restricted subsidiary” under the applicable indenture; (ii) if the Guarantor merges with and into Scotts Miracle-Gro, with Scotts Miracle-Gro surviving such merger; (iii) if the Guarantor is designated an “unrestricted subsidiary” in accordance with the applicable indenture or otherwise ceases to be a “restricted subsidiary” (including by way of liquidation or dissolution) in a transaction permitted by such indenture; (iv) upon legal or covenant defeasance; (v) at the election of Scotts Miracle-Gro following the Guarantor’s release as a guarantor under the Seventh A&R Credit Agreement, except a release by or as a result of the repayment of the Seventh A&R Credit Agreement; or (vi) if the Guarantor ceases to be a “restricted subsidiary” and the Guarantor is not otherwise required to provide a guarantee of the Senior Notes pursuant to the applicable indenture.

Our foreign subsidiaries and certain of our domestic subsidiaries are not guarantors (collectively, the “Non-Guarantors”) of the Senior Notes. Payments on the Senior Notes are only required to be made by Scotts Miracle-Gro and the Guarantors. As a result, no payments are required to be made from the assets of the Non-Guarantors, unless those assets are transferred by dividend or otherwise to Scotts Miracle-Gro or a Guarantor. In the event of a bankruptcy, insolvency, liquidation or reorganization of any of the Non-Guarantors, holders of their indebtedness, including their trade creditors and other obligations, will be entitled to payment of their claims from the assets of the Non-Guarantors before any assets are made available for distribution to Scotts Miracle-Gro or the Guarantors. As a result, the Senior Notes are effectively subordinated to all the liabilities of the Non-Guarantors.

Contents THE SCOTTS MIRACLE-GRO COMPANY
(Dollars in millions, except per share data)

The guarantees may be subject to review under federal bankruptcy laws or relevant state fraudulent conveyance or fraudulent transfer laws. In certain circumstances, the court could void the guarantee, subordinate the amounts owing under the guarantee, or take other actions detrimental to the holders of the Senior Notes.

As a general matter, value is given for a transfer or an obligation if, in exchange for the transfer or obligation, property is transferred or a valid antecedent debt is satisfied. A court would likely find that a Guarantor did not receive reasonably equivalent value or fair consideration for its guarantee to the extent such Guarantor did not obtain a reasonably equivalent benefit from the issuance of the Senior Notes.

The measure of insolvency varies depending upon the law of the jurisdiction that is being applied. Regardless of the measure being applied, a court could determine that a Guarantor was insolvent on the date the guarantee was issued, so that payments to the holders of the Senior Notes would constitute a preference, fraudulent transfer or conveyances on other grounds. If a guarantee is voided as a fraudulent conveyance or is found to be unenforceable for any other reason, the holders of the Senior Notes will not have a claim against the Guarantor.

Each guarantee contains a provision intended to limit the Guarantor’s liability to the maximum amount that it could incur without causing the incurrence of obligations under its guarantee to be a fraudulent conveyance. However, there can be no assurance as to what standard a court will apply in making a determination of the maximum liability of each Guarantor. Moreover, this provision may not be effective to protect the guarantees from being voided under fraudulent conveyance laws. There is a possibility that the entire guarantee may be set aside, in which case the entire liability may be extinguished.

The following tables present summarized financial information on a combined basis for Scotts Miracle-Gro and the Guarantors. Transactions between Scotts Miracle-Gro and the Guarantors have been eliminated and the summarized financial information does not reflect investments of the Scotts Miracle-Gro and the Guarantors in the Non-Guarantor subsidiaries.

March 28, 2026 September 30, 2025
Current assets $1,420.9 $831.9
Non-current assets (a) 1,734.7 1,657.4
Current liabilities 1,173.6 640.9
Non-current liabilities 2,367.0 2,297.4

(a) Includes amounts due from Non-Guarantor subsidiaries of $92.3 and $11.4, respectively.

Six Months Ended March 28, 2026 Year Ended September 30, 2025
Net sales $1,715.7 $3,018.5
Gross margin 677.4 980.0
Net income from continuing operations 216.2 196.3
Net income (a) 113.2 180.4

(a) Includes intercompany income from Non-Guarantor subsidiaries of $2.9 and $5.9, respectively.

Judicial and Administrative Proceedings

We are party to various pending judicial and administrative proceedings and claims arising in the ordinary course of business relating to, among others, product and general liabilities, workers’ compensation, property losses and other liabilities for which we are self-insured or retain a high exposure limit. We have reviewed these pending judicial and administrative proceedings, including the probable outcomes, reasonably anticipated costs and expenses, and the availability and limits of our insurance coverage, and have established what we believe to be appropriate accruals. We believe that our assessment of contingencies is reasonable and related accruals are adequate, both individually and in the aggregate; however, there can be no assurance that final resolution of these matters will not have a material effect on our financial condition, results of operations or cash flows.

Contents THE SCOTTS MIRACLE-GRO COMPANY
(Dollars in millions, except per share data)

REGULATORY MATTERS

We are subject to local, state, federal and foreign environmental protection laws and regulations with respect to our business operations and believe we are operating in substantial compliance, or taking actions aimed at ensuring compliance, with such laws and regulations. We are involved in several legal actions with various governmental agencies related to environmental matters. While it is difficult to quantify the potential financial impact of actions involving these environmental matters, particularly remediation costs at waste disposal sites and future capital expenditures for environmental control equipment, in the opinion of management, the ultimate liability arising from such environmental matters, taking into account established accruals, is not expected to have a material effect on our financial condition, results of operations or cash flows. However, there can be no assurance that the resolution of these matters will not materially affect our future quarterly or annual results of operations, financial condition or cash flows. Additional information on environmental matters affecting us is provided in the 2025 Annual Report, under “ITEM 1. BUSINESS — Regulatory Considerations” and “ITEM 3. LEGAL PROCEEDINGS.”

CRITICAL ACCOUNTING ESTIMATES

Our unaudited condensed consolidated financial statements have been prepared in accordance with GAAP. The preparation of financial statements and related disclosures in accordance with GAAP requires management to use judgment and make estimates that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosures of contingent assets and liabilities. We evaluate our estimates on an ongoing basis. By their nature, these judgments are subject to uncertainty. We base our estimates on historical experience, current trends and other factors that we believe to be relevant under the circumstances at the time the estimate was made. Certain accounting estimates are particularly significant, including those related to revenue recognition and promotional allowances, income taxes and goodwill and indefinite-lived intangible assets.

We believe that our estimates, assumptions, and judgments are reasonable in that they were based on information available when the estimates, assumptions and judgments were made. However, because future events and their effects cannot be determined with certainty, actual results could differ materially from those implied by our assumptions and estimates.

The Audit Committee of the Board of Directors of Scotts Miracle-Gro reviews our critical accounting estimates on an ongoing basis, including those related to revenue recognition and promotional allowances, income taxes and goodwill and indefinite-lived intangible assets. Our critical accounting estimates have not changed materially from those disclosed in the 2025 Annual Report.

Market risk

As filed, 219 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Management believes that there are no material changes to our quantitative and qualitative disclosures about market risks during the six months ended March 28, 2026 compared to those disclosed in the 2025 Annual Report.

Controls and procedures

As filed, 1,669 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

The Scotts Miracle-Gro Company (the “Registrant”) maintains “disclosure controls and procedures,” as such term is defined under the Securities Exchange Act of 1934 (the “Exchange Act”) Rule 13a-15(e), that are designed to ensure that information required to be disclosed in the Registrant’s Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to the Registrant’s management, including its principal executive officer and its principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

With the participation of the principal executive officer and the principal financial officer of the Registrant, the Registrant’s management has evaluated the effectiveness of the Registrant’s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act), as of the end of the fiscal quarter covered by this Form 10-Q. Based upon that evaluation, the Registrant’s principal executive officer and principal financial officer have concluded that the Registrant’s disclosure controls and procedures were effective as of March 28, 2026.

Changes in Internal Control Over Financial Reporting

No changes in the Registrant’s internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) occurred during the Registrant’s fiscal quarter ended March 28, 2026 that have materially affected, or are reasonably likely to materially affect, the Registrant’s internal control over financial reporting.

Risk factors

As filed, 2,987 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The Company’s risk factors, as of March 28, 2026, have not materially changed from those described in Part I, Item 1A of the 2025 Annual Report.

Cautionary Note Regarding Forward-Looking Statements

This Form 10-Q, including the exhibits hereto and the information incorporated by reference herein, contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act, which are subject to risks and uncertainties. Information regarding activities, events and developments that we expect or anticipate will or may occur in the future, including, but not limited to, information relating to our future growth and profitability targets and strategies designed to increase total shareholder value, are forward-looking statements based on management’s estimates, assumptions and projections. Forward-looking statements also include, but are not limited to, statements regarding our future economic and financial condition and results of operations, the plans and objectives of management and our assumptions regarding our performance and such plans and objectives, as well as the amount and timing of dividends and repurchases of Common Shares or other uses of cash flows. Forward-looking statements generally can be identified through the use of words such as “guidance,” “outlook,” “projected,” “believe,” “target,” “predict,” “estimate,” “forecast,” “strategy,” “may,” “goal,” “expect,” “anticipate,” “intend,” “plan,” “foresee,” “likely,” “will,” “should” and other similar words and variations.

Forward-looking statements in this Form 10-Q are predictions only and actual results could differ materially from management’s expectations due to a variety of factors, including those described in “ITEM 1A. RISK FACTORS” in the 2025 Annual Report. All forward-looking statements attributable to us or persons working on our behalf are expressly qualified in their entirety by such risk factors and other cautionary statements that we make from time to time in our other SEC filings and public communications.

You should evaluate forward-looking statements in the context of these risks and uncertainties and are cautioned not to place undue reliance on such statements. These factors may not contain all of the factors that are important to you. We cannot assure you that we will realize the results or developments we expect or anticipate or, even if substantially realized, that they will result in the consequences or affect us or our operations in the way we expect. The forward-looking statements that we make in this Form 10-Q are based on management’s current views and assumptions regarding future events and speak only as of their dates. We disclaim any obligation to update developments of these risk factors or to announce publicly any revisions to any of the forward-looking statements that we make, or to make corrections to reflect future events or developments, except as required by law.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2026-03-28. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2025-12-28 to 2026-03-28$1.46bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2025-10-01 to 2026-03-28$1.81bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2025-12-28 to 2026-03-28$849.0mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2025-10-01 to 2026-03-28$1.11bnus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2025-12-28 to 2026-03-28$610.5mus-gaap:GrossProfit
Gross profit6 months2025-10-01 to 2026-03-28$699.2mus-gaap:GrossProfit
Selling, general and administrative3 months2025-12-28 to 2026-03-28$199.2mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2025-10-01 to 2026-03-28$305.1mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2025-12-28 to 2026-03-28$401.8mus-gaap:OperatingIncomeLoss
Operating income6 months2025-10-01 to 2026-03-28$380.0mus-gaap:OperatingIncomeLoss
Interest expense3 months2025-12-28 to 2026-03-28$31.3mus-gaap:InterestExpense
Interest expense6 months2025-10-01 to 2026-03-28$58.5mus-gaap:InterestExpense
Income tax3 months2025-12-28 to 2026-03-28$101.6mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2025-10-01 to 2026-03-28$86.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2025-12-28 to 2026-03-28$238.6mus-gaap:NetIncomeLoss
Net income6 months2025-10-01 to 2026-03-28$113.6mus-gaap:NetIncomeLoss
Diluted EPS3 months2025-12-28 to 2026-03-28$4.04us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2025-10-01 to 2026-03-28$1.93us-gaap:EarningsPerShareDiluted
Basic EPS3 months2025-12-28 to 2026-03-28$4.11us-gaap:EarningsPerShareBasic
Basic EPS6 months2025-10-01 to 2026-03-28$1.96us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2025-12-28 to 2026-03-2859,100,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2025-10-01 to 2026-03-2859,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2025-10-01 to 2026-03-28−$150.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2025-10-01 to 2026-03-28$38.6mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2025-10-01 to 2026-03-28$77.8mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases6 months2025-10-01 to 2026-03-28$11.6mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2026-03-28$6.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2026-03-28$1.62bnus-gaap:AssetsCurrent
Total assetsAt period end2026-03-28$3.41bnus-gaap:Assets
Current liabilitiesAt period end2026-03-28$1.28bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2026-03-28$3.70bnus-gaap:Liabilities
Long-term debtAt period end2026-03-28$2.07bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2026-03-28$279.4mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2026-03-28−$286.5mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000825542-26-000024. Last ingested by Listed: Nov 14, 2026, 14:28 ET. Listed shows no prices and gives no investment advice.